The potential efficacy of Survanta (r) and Seprafilm (r) on preventing intra-abdominal adhesions in rats

Abstract

PURPOSE:To investigate the potential efficacy of beractant (Survanta ® ) and Seprafilm ® on the prevention of postoperative adhesions. METHODS:Forty Wistar-albino female rats were used. The rats were randomly allocated into four groups of 10 rats each as control group (CG), beractant group (BG), Seprafilm ® group (SG), and combined group (COG). All rats underwent cecal abrasion via midline laparotomy. Before abdominal closure, isotonic saline, beractant, Seprafilm, and combined agents were intraperitoneally administered. Adhesions were classified macroscopically with Canbaz Scoring System on postoperative day 10. Ceacum was resected for histopathological assessment. RESULTS:Macroscopic adhesion scores were significantly lower in BG, SG, and COG than CG (p<0.05); (45%, 15%, 25%, and 15%; respectively). Histopathological assessment revealed a reduced inflammation and fibrosis score in the study groups than CG (p<0.05).In BG, adhesion development, inflammation and fibrosis scores were lower than SG; however, it was not statistically significant. CONCLUSIONS:Intra-abdominal application of beractant is significantly effective for the prevention of adhesion formation with no adverse effect by covering the whole peritoneal mesothelium with excellent gliding properties in a rat model. The combination of both agents is also effective in reducing adhesion formation, however, not superior to single beractant application.

Adhesive Process as a Problem of Oncology Abdominal Operative Surgery

“…Кроме того, за счет модифици-рованной гиалуроновой кислоты препарат может привести к несостоятельности анастомозов, об-разованию внутрибрюшных абсцессов [46]. Ком-бинация «Сепрафилм» и берактант «Сюрванта» эффективна для уменьшения спайкообразования, однако она не превосходит по результатам одно-кратное внутрибрюшное применение берактанта «Сюрванта» [55].…”